<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0001978'>Extramedullary hematopoiesis</z:hpo> (<z:mp ids='MP_0000240'>EMH</z:mp>) is a relatively rare, but well-documented, manifestation of <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0005547'>myeloproliferative disorders</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Microscopically, foci of <z:mp ids='MP_0000240'>EMH</z:mp> consist of erythroid and myeloid precursors intermixed with megakaryocytes </plain></SENT>
<SENT sid="2" pm="."><plain>It typically occurs in the spleen and liver, but very occasionally manifests as cutaneous <z:mp ids='MP_0000240'>EMH</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>We report a 76-year-old Japanese man with cutaneous <z:mp ids='MP_0000240'>EMH</z:mp> arising from <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> associated with <z:hpo ids='HP_0011974'>myelofibrosis</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>His cutaneous manifestations showed multiple skin-colored firm nodules over the head, trunk, and extremities </plain></SENT>
<SENT sid="5" pm="."><plain>We detected high plasma levels of transforming growth factor (TGF)-beta1 in our patient </plain></SENT>
<SENT sid="6" pm="."><plain>Immunohistochemical analysis of the skin biopsy sample revealed TGF-beta1 overexpression in immature hematopoietic cells and dermal fibroblasts within the cutaneous <z:mp ids='MP_0000240'>EMH</z:mp> mass of the dermis </plain></SENT>
<SENT sid="7" pm="."><plain>These findings suggest that TGF-beta could play some role in the <z:hpo ids='HP_0003674'>onset</z:hpo> of cutaneous <z:mp ids='MP_0000240'>EMH</z:mp> </plain></SENT>
<SENT sid="8" pm="."><plain>Five months after his first visit to our dermatologic clinic, the patient developed <z:hpo ids='HP_0005528'>bone-marrow failure</z:hpo> and died </plain></SENT>
<SENT sid="9" pm="."><plain>Based on our observations, accelerated <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> in the bone marrow should be considered in any patient with cutaneous <z:mp ids='MP_0000240'>EMH</z:mp> </plain></SENT>
<SENT sid="10" pm="."><plain>It is presumed that TGF-beta released from hematopoietic cells within the cutaneous <z:mp ids='MP_0000240'>EMH</z:mp> play a critical role in the activation of <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">hematologic malignancy</z:e> </plain></SENT>
</text></document>